REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $266,934,599 | +6.8% | 9,643,591 | +3.2% | 0.01% | +16.7% |
Q2 2023 | $249,858,456 | +24.0% | 9,340,503 | +0.4% | 0.01% | +20.0% |
Q1 2023 | $201,493,299 | +11.9% | 9,302,553 | +23.0% | 0.01% | 0.0% |
Q4 2022 | $180,124,696 | +30.8% | 7,561,910 | +8.3% | 0.01% | +25.0% |
Q3 2022 | $137,725,000 | +26.9% | 6,984,002 | +25.5% | 0.00% | +33.3% |
Q2 2022 | $108,502,000 | -29.8% | 5,567,012 | -8.1% | 0.00% | -25.0% |
Q1 2022 | $154,538,000 | -2.5% | 6,057,931 | -3.8% | 0.00% | 0.0% |
Q4 2021 | $158,562,000 | -7.6% | 6,299,609 | +1.0% | 0.00% | 0.0% |
Q3 2021 | $171,668,000 | +2.7% | 6,240,198 | +18.4% | 0.00% | 0.0% |
Q2 2021 | $167,224,000 | -24.9% | 5,268,564 | +8.6% | 0.00% | -33.3% |
Q1 2021 | $222,530,000 | +39.2% | 4,850,262 | +20.1% | 0.01% | +20.0% |
Q4 2020 | $159,858,000 | +33.1% | 4,037,820 | +17.0% | 0.01% | +25.0% |
Q3 2020 | $120,064,000 | +188.4% | 3,450,101 | +161.6% | 0.00% | +300.0% |
Q2 2020 | $41,634,000 | +74.4% | 1,318,767 | +21.0% | 0.00% | 0.0% |
Q1 2020 | $23,875,000 | – | 1,089,650 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |